- Home
- ZLAB vs QFIN Comparison
ZLAB vs QFIN Comparison
Compare ZLAB & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- QFIN
- Stock Information
- Founded
- ZLAB 2013
- QFIN 2016
- Country
- ZLAB China
- QFIN China
- Employees
- ZLAB N/A
- QFIN N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- QFIN Finance: Consumer Services
- Sector
- ZLAB Health Care
- QFIN Finance
- Exchange
- ZLAB Nasdaq
- QFIN Nasdaq
- Market Cap
- ZLAB 3.4B
- QFIN 3.8B
- IPO Year
- ZLAB 2017
- QFIN 2018
- Fundamental
- Price
- ZLAB $32.58
- QFIN $30.76
- Analyst Decision
- ZLAB Buy
- QFIN Strong Buy
- Analyst Count
- ZLAB 6
- QFIN 2
- Target Price
- ZLAB $57.22
- QFIN $45.10
- AVG Volume (30 Days)
- ZLAB 819.9K
- QFIN 1.6M
- Earning Date
- ZLAB 11-11-2025
- QFIN 08-14-2025
- Dividend Yield
- ZLAB N/A
- QFIN 4.95%
- EPS Growth
- ZLAB N/A
- QFIN 68.82
- EPS
- ZLAB N/A
- QFIN 7.06
- Revenue
- ZLAB $427,799,000.00
- QFIN $2,618,582,596.00
- Revenue This Year
- ZLAB $42.62
- QFIN $15.44
- Revenue Next Year
- ZLAB $55.12
- QFIN $6.45
- P/E Ratio
- ZLAB N/A
- QFIN $4.08
- Revenue Growth
- ZLAB 32.56
- QFIN 9.77
- 52 Week Low
- ZLAB $20.17
- QFIN $24.85
- 52 Week High
- ZLAB $44.34
- QFIN $48.94
- Technical
- Relative Strength Index (RSI)
- ZLAB 48.51
- QFIN 51.17
- Support Level
- ZLAB $31.68
- QFIN $28.10
- Resistance Level
- ZLAB $33.06
- QFIN $28.98
- Average True Range (ATR)
- ZLAB 1.34
- QFIN 0.93
- MACD
- ZLAB 0.21
- QFIN 0.43
- Stochastic Oscillator
- ZLAB 80.97
- QFIN 91.76
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About QFIN Qifu Technology Inc.
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.